Presentation Information
[D1-A3-01]After the Implementation of ICH-M10 Guideline: Questions and Concerns in the Real Bioanalytical Field
* (Chairpersons) Yuki Takamatsu1, *Hisanori Hara2 (1. Takeda Pharmaceutical Co., Ltd., 2. B2S Life Sciences)
Password required to view
Log in
or